结果最常见病理类型为系膜增生性肾炎，占43.3%。
Results The most pathological type is mesangial proliferative glomerulonephritis (43.3%).
结论：疏肝化瘀法是治疗系膜增生性肾炎的有效方法之一。
Conelusion: Liver-Dredging and Stasis-Dispersing Method is a kind of effective treatments to treat MsPGN.
结论：疏肝化瘀法是治疗系膜增生性肾炎的有效方法之一。
N. Conelusion: Liver-Dredging and Stasis-Dispersing Method is a kind of effective treatments to treat MsPGN.
本研究通过回顾性研究观察疏肝化瘀法对系膜增生性肾炎的临床疗效。
This study observed the clinical effect of Liver-Dredging and Stasis-Dispersing Method to MsPGN.
结果观察组系膜增生性肾炎的复发率及强的松副作用的发生率显著低于对照组（P< 0 .0 1）。
Results The recurrent rate of disease and occurrence rate of side-effects of prednisone in the treated group were less than in the control group significantly(P<0.01).
纵观过去30多年时间，II型膜增生性肾小球肾炎与致密物沉积病两者的病因学和发病机理已经表露出了显著差别。
Over the last 30 years, marked differences in etiology and pathogenesis between type II membranoproliferative glomerulonephritis and dense deposit disease have become apparent.
提示，临床上LMWH能通过对增生性肾炎患者系膜细胞增殖和系膜基质积聚的抑制作用而发挥效应。
The effect of LMWH on patients with proliferative glomerulonephritis may be associated with inhibiting the proliferation of mesangial cell and the accumulation of mesangial matrix.
电镜下膜增生性肾小球肾炎ii型，基底膜有电子致密物沉积。
This electron micrograph demonstrates the dense deposits in the basement membrane of MPGN type II.
给大鼠注射抗胸腺细胞血清（ATS）复制系膜增生性肾小球肾炎即ATS性肾炎（ATSN）模型。
The model of mesangioproliferative nephritis of rats, namely, anti- thymocyte serum nephritis (ATSN) was established by repeated injection of rabbit antiserum against rat thymocytes.
总结原发性肾病综合征系膜增生性肾小球肾炎的诊治经验。
Objective Diagnosis and treatment experience of primary nephrotic syndrome mesangial proliferative glomerulonephritis are discussed in the article.
总结原发性肾病综合征系膜增生性肾小球肾炎的诊治经验。
Objective Diagnosis and treatment experience of primary nephrotic syndrome mesangial proliferative glomerulonephritis are discussed in the article.
应用推荐